Emma C. Thomson

42.7k total citations · 2 hit papers
90 papers, 4.0k citations indexed

About

Emma C. Thomson is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Emma C. Thomson has authored 90 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 37 papers in Infectious Diseases and 33 papers in Epidemiology. Recurrent topics in Emma C. Thomson's work include Hepatitis C virus research (35 papers), Hepatitis B Virus Studies (23 papers) and Liver Disease Diagnosis and Treatment (19 papers). Emma C. Thomson is often cited by papers focused on Hepatitis C virus research (35 papers), Hepatitis B Virus Studies (23 papers) and Liver Disease Diagnosis and Treatment (19 papers). Emma C. Thomson collaborates with scholars based in United Kingdom, United States and Germany. Emma C. Thomson's co-authors include David L. Robertson, William T. Harvey, Ravindra K. Gupta, Alessandro M. Carabelli, Sharon J. Peacock, Andrew Rambaut, Ben Jackson, Ewan M. Harrison, Catherine Ludden and Richard Reeve and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Emma C. Thomson

82 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 variants, spike mutations and immune escape

2021 2.1k citations William T. Harvey, Emma C. Thomson et al. profile →
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies

2022 171 citations Thomas P. Peacock, William T. Harvey et al. profile →

Peers

Countries citing papers authored by Emma C. Thomson

Since Specialization

Citations

This map shows the geographic impact of Emma C. Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma C. Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma C. Thomson more than expected).

Fields of papers citing papers by Emma C. Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma C. Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma C. Thomson. The network helps show where Emma C. Thomson may publish in the future.

Co-authorship network of co-authors of Emma C. Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of Emma C. Thomson. A scholar is included among the top collaborators of Emma C. Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma C. Thomson. Emma C. Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024 2025 ·EBioMedicine ·(unknown), Sam Scott, Nicola S. Logan, (unknown), Joseph Newman, Igor Andrade Santos, Dalan Bailey, Pablo R. Murcia, Emma C. Thomson, Margaret J. Hosie, Brian J. Willett	1
2	Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis 2024 ·Clinical Infectious Diseases ·(unknown), Philippa Easterbrook, (unknown), Nathan Ford, William L. Irving, Philippa C. Matthews, Marco Vitória, Chris Duncombe, Amalia Girón‐Callejas, Suzanne M. McCluskey, Olufunmilayo Lesi, S. Tchamgoué, Rachel Halford, (unknown), Emma C. Thomson, Geoff Dusheiko, Michael R. Jordan	1
3	Identification and distribution of Rhipicephalus microplus in selected high-cattle density districts in Uganda: signaling future demand for novel tick control approaches 2024 ·BMC Veterinary Research ·(unknown), (unknown), Joseph Nkamwesiga, (unknown), Charles Byaruhanga, Steven Odongo, Patrick Vudriko, (unknown), (unknown), Joseph Erume, Charles Masembe, Emma C. Thomson, Dennis Muhanguzi, Robert Tweyongyere	6
4	EMERGING VIRUSES ARE AN UNDERESTIMATED CAUSE OF UNDIAGNOSED FEBRILE ILLNESS IN UGANDA 2023 ·International Journal of Infectious Diseases ·Shirin Ashraf, (unknown), Christopher Davis, James G. Shepherd, Vattipally B. Sreenu, Ana da Silva Filipe, (unknown), Martin N. Mayanja, R. G. Downing, (unknown), Henry Bukenya, (unknown), (unknown), (unknown), Stephen Balinandi, Julius J. Lutwama, Pontiano Kaleebu, Josephine Bwogi, Emma C. Thomson	4
5	Emerging Rhabdoviruses and Human Infection 2023 ·Biology ·James G. Shepherd, Christopher Davis, Daniel G. Streicker, Emma C. Thomson	15
6	Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study 2023 ·Epidemiology and Infection ·Sema Nickbakhsh, E. Carol McWilliam Leitch, (unknown), Christopher Davis, Sharon Hutchinson, William L. Irving, John McLauchlan, Emma C. Thomson	1
7	Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment 2022 ·Viruses ·Rajiv Shah, Stephen T. Barclay, (unknown), Ray Fox, Rory Gunson, Amanda Bradley-Stewart, Samantha J. Shepherd, Alasdair Maclean, L. Tong, (unknown), (unknown), Ana da Silva Filipe, Emma C. Thomson, Christopher Davis	1
8	SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity 2022 ·The Journal of Infectious Diseases ·Maria Manali, (unknown), (unknown), Nicola Logan, Sam Scott, (unknown), William T. Harvey, Richard Orton, Emma C. Thomson, Rory Gunson, Mafalda Viana, Brian J. Willett, Pablo R. Murcia	7
9	Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy 2021 ·Journal of Viral Hepatitis ·David A. Smith, Daniel Bradshaw, Jean L. Mbisa, Carmen F. Manso, David Bibby, Joshua B. Singer, Emma C. Thomson, Ana da Silva Filipe, Elihú Aranday-Cortés, M. Azim Ansari, Anthony Brown, Emma Hudson, (unknown), Brendan Healy, (unknown), John McLauchlan, Eleanor Barnes, William L. Irving	19
10	Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination 2021 ·PLoS Pathogens ·Christopher Davis, Nicola Logan, Grace Tyson, Richard Orton, William T. Harvey, (unknown), Guy Mollett, Rachel Blacow, Thomas P. Peacock, William Barclay, Peter Cherepanov, Massimo Palmarini, Pablo R. Murcia, Arvind H. Patel, David L. Robertson, John Haughney, Emma C. Thomson, Brian J. Willett, (unknown)	117
11	Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland 2021 ·Archives of Disease in Childhood ·Rachael Wood, Emma C. Thomson, Robert M. Galbraith, Ciara Gribben, David Caldwell, Jennifer L. Bishop, Martin Reid, Anoop Shah, Kate Templeton, David Goldberg, Chris Robertson, Sharon Hutchinson, Helen M. Colhoun, Paul McKeigue, David McAllister	24
12	Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care 2021 ·Genome Medicine ·Andrew Bosworth, Natasha Y. Rickett, Xiaofeng Dong, Lisa F. P. Ng, Isabel García-Dorival, David A. Matthews, Tom Fletcher, Michael Jacobs, Emma C. Thomson, Miles W. Carroll, Julian A. Hiscox	9
13	Interpreting Viral Deep Sequencing Data with GLUE 2019 ·Viruses ·Joshua B. Singer, Emma C. Thomson, Joseph Hughes, Elihú Aranday-Cortés, John McLauchlan, Ana da Silva Filipe, L. Tong, Carmen F. Manso, Robert J. Gifford, David L. Robertson, Eleanor Barnes, M. Azim Ansari, Jean L. Mbisa, David Bibby, Daniel Bradshaw, David A. Smith	17
14	Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing 2019 ·Journal of Clinical Virology ·Sally A. Baylis, Kay-Martin Hanschmann, Keiji Matsubayashi, Hidekatsu Sakata, Anne‐Marie Roque‐Afonso, Marco Kaiser, Victor M. Corman, Saleem Kamili, Rakesh Aggarwal, Nirupma Trehanpati, (unknown), Emma C. Thomson, Christopher Davis, Ana da Silva Filipe, Tamir Abdelrahman, Johannes Blümel, (unknown)	12
15	GLUE: a flexible software system for virus sequence data 2018 ·BMC Bioinformatics ·Joshua B. Singer, Emma C. Thomson, John McLauchlan, Joseph Hughes, Robert J. Gifford	54
16	DURABILITY OF IMMUNE RESPONSES INDUCED BY THREE LEADING CANDIDATE EBOLA VACCINE REGIMES; RVSV ZEBOV, CHAD3 EBO Z-MVA BN-FILO AND ADHU26. ZEBOV-MVA BN FILO 2018 ·American Journal of Tropical Medicine and Hygiene ·Katie Ewer, Christopher M. Smith, (unknown), Georgina Bowyer, Tommy Rampling, Catherine Mair, Duncan Bellamy, (unknown), Christopher J. Davies, Navin Venkatraman, Rebecca Conway-Jones, (unknown), C. Boyer, (unknown), Emma C. Thomson, (unknown)	1
17	Comparison of real-world hypoglycemia rates among Patients Initiating Treatment with Saxagliptin or Glipizide 2015 ·Value in Health ·Stephen S. Johnston, Kelly Bell, Emma C. Thomson, Gregory Lenhart, John P. Sheehan	1
18	Intravenous methamphetamine use is associated with lower sustained virological response rates in HIV-positive men who have sex with men infected with acute hepatitis C 2011 ·HIV Medicine ·Emma C. Thomson, Janice Main, Peter Karayiannis, Paul Klenerman	2
19	Dynamic Coinfection with Multiple Viral Subtypes in Acute Hepatitis C 2010 ·The Journal of Infectious Diseases ·Jennifer Smith, Judith H. Aberle, Vicki M. Fleming, Peter Ferenci, Emma C. Thomson, Peter Karayiannis, Angela R. McLean, Heidemarie Holzmann, Paul Klenerman	22
20	Advances in hepatitis B and C 2004 ·Current Opinion in Infectious Diseases ·Emma C. Thomson, Janice Main	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact